icon-folder.gif   Conference Reports for NATAP  
 
  66th Annual Meeting of the
American Association for the
Study of Liver Diseases
Boston, MA Nov 13-17 2015
Back grey_arrow_rt.gif
 
 
 
Effectiveness of 8 or 12 week LDV-SOF in Treatment-Na´ve Patients with Non-Cirrhotic, Genotype 1 Hepatitis C: Real-World Experience from the TRIO Network
 
 
  Reported by Jules Levin
AASLD 2015 Nov 13-17 San Francisco
 
Michael P. Curry1, Bruce Bacon2, Douglas Dieterich3, Steven L. Flamm4, Lauren Guest5, Kris V. Kowdley6, YooriLee5, NaokyTsai7, ZobairYounossi8 1Beth Israel Deaconess Medical Center, 2Saint Louis University School of Medicine,3Mount Sinai School of Medicine, 4Northwestern University Feinberg School of Medicine,5Trio Health Analytics, 6 Swedish Liver Center and Transplant Program,
Swedish Medical Center, 7Queens Medical Center, University of Hawaii, 8Center for Liver Diseases, Department of Medicine, InovaFairfax Hospital

AASLD1.gif

AASLD2.gif

AASLD3.gif

AASLD4.gif

AASLD5.gif

AASLD6.gif

AASLD7.gif

AASLD8.gif

AASLD9.gif